Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Webinars

  • The Truth about Doctors

    Thursday, 19 October 2017 - 3:00 pm

    ‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and how we can improve the way we communicate to them.

    Dominic Tyer, Editorial director

    FREE | REGISTER NOW

  • Proving the Strategic Value of Patients

    Tuesday, 10 October 2017 - 3:00 pm

    Patient insights aren’t just a ‘nice to have’: they are essential to understand the space where Pharma’s drugs ‘live’.

    Dominic Tyer, Editorial director

    FREE | REGISTER NOW

  • Regret Minimisation

    Tuesday, 11 July 2017 - 3:00 pm

    When new products approach the market the level of demand for them is often exaggerated.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Assessing early market opportunity

    Wednesday, 19 April 2017 - 3:00 pm

    To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • PC: Are you Patient Centric or just Politically Correct?

    Tuesday, 24 January 2017 - 3:00 pm

    Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Communicating innovation to payers and policy makers

    Monday, 28 November 2016 - 3:00 pm

    Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Immuno-oncology's evolution: implications for pharma market researche

    Thursday, 17 November 2016 - 3:00 pm

    Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Scale & Strategy: Essential tools for transforming the commercial model

    Wednesday, 9 November 2016 - 2:00 pm

    Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Driving adoption of Commercial Analytic solutions Driving adoption of Commercial Analytic solutions

    Tuesday, 25 October 2016 - 3:00 pm

    Measuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making

    Tuesday, 4 October 2016 - 3:00 pm

    Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Strengthening market access deliverables by harnessing the patient journey

    Wednesday, 14 September 2016 - 3:00 pm

    In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • The value of early asset development and commercialisation

    Wednesday, 13 July 2016 - 3:00 pm

    Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets to succeed.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Developing medical education that advances patient outcomes

    Thursday, 30 June 2016 - 2:00 pm

    As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice and advancing patient outcomes.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Customer engagement design in pharma

    Thursday, 19 May 2016 - 3:00 pm

    In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Rare diseases: Regulatory and reimbursement submissions, the challenges

    Tuesday, 22 March 2016 - 3:00 pm

    Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Meaningful digital initiatives need face time

    Wednesday, 10 February 2016 - 3:00 pm

    Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Authentic Engagement in Healthcare thumb Authentic Engagement in Healthcare

    Tuesday, 24 November 2015 - 2:00 pm

    What does ‘authenticity’ mean to the healthcare sector and how can companies best build authentic relationships with their stakeholders?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Can medical technology afford market access?

    Wednesday, 18 November 2015 - 3:00 pm

    Medical technologies should be innovative, unique, and have technical feasibility and robust intellectual property. This does not, however, guarantee successful market access and reimbursement.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Drivers for change – payer value perceptions

    Tuesday, 22 September 2015 - 3:00 pm

    In an ever-changing healthcare environment, the need to prove value for money remains a key focus for payers and reimbursement decision makers.

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

  • Sales reps in the digital age

    Thursday, 9 July 2015 - 1:00 pm

    As the number of doctors willing to see pharmaceutical sales representatives in person declines how digital tools can help with access, reach and rep effectiveness?

    Dominic Tyer, Editorial director

    FREE | VIEW NOW

Previous 1 2 3 Next

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

14_ipad_lowres.jpg
Why AI might be the rep’s best friend
When looking for the next big thing in digital communication, there’s nothing bigger than the sweeping changes promised by artificial intelligence. There’s little doubt that AI is coming to pharma...
How Transparent Is Transparency?
The second annual publication of transfer of value (TOV) data has just been publically disclosed. For those of you that it passed by, it seems to have generated very little...
Geraldine Murphy
LEO: Patients benefit from transparency
Paving the way for openness in pharma...

Quick links

Infographics

Multimedia